Prevalence of type 2 diabetes (T2D) in Lebanon: association with inflammatory and infectious clinical markers

被引:1
|
作者
Chedid, Pia [1 ]
Sokhn, Elie Salem [1 ,2 ]
机构
[1] Beirut Arab Univ, Fac Hlth Sci, Med Lab Dept, Mol Testing Lab, Beirut, Lebanon
[2] Geitaoui Univ, Lebanese Hosp, Lab Dept, Med Ctr, Beirut, Lebanon
关键词
HbA1c; Type; 2; diabetes; Prevalence; Inflammation; Infection; Clinical markers; NEUTROPHIL-LYMPHOCYTE RATIO; URINARY-TRACT-INFECTIONS; SERUM-CALCIUM; RISK-FACTORS; MIDDLE-EAST; MELLITUS; DIAGNOSIS; GLUCOSE; HOMEOSTASIS; POPULATION;
D O I
10.1186/s12889-023-17328-6
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Diabetes is a growing health concern in the Middle East, particularly in countries with high rates of obesity and unhealthy lifestyles. Therefore, this study aimed to determine the prevalence of type 2 diabetes (T2D) in Lebanon and its association with clinical markers of inflammation and infection.Methods This cross-sectional study examined retrospectively the medical laboratory record of 4093 patients from all Lebanese regions.Prevalence of T2D and its association with age, gender, calcium, vitamin D (VitD), neutrophils-to-lymphocytes ratio (NLR), and C-reactive protein (CRP) were determined. The prevalence of infection in a subpopulation of 712 patients tested from blood, body fluid, sputum, swab, tissue, and urine samples and its etiology was also assessed.Methods This cross-sectional study examined retrospectively the medical laboratory record of 4093 patients from all Lebanese regions. Prevalence of T2D and its association with age, gender, calcium, vitamin D (VitD), neutrophils-to-lymphocytes ratio (NLR), and C-reactive protein (CRP) were determined. The prevalence of infection in a subpopulation of 712 patients tested from blood, body fluid, sputum, swab, tissue, and urine samples and its etiology was also assessed.Results Overall, 17% (n = 690) of our participants had T2D, and the mean HbA1c was 5.9% +/- 1.2. Age, gender, triglycerides, NLR, and calcemia were significantly associated with T2D. The prevalence of infections in a subgroup of 712 patients was 11.1% (n = 79). Urinary tract infections (UTIs) caused by Escherichia coli (E. coli) were the most common cause of infection, with the highest prevalence in the pre-diabetic group. Serum CRP level was significantly higher in the diabetic group than the pre-diabetic and control groups. Diabetic patients also presented a significantly higher percentage of NLR > 3 compared to the pre-diabetic and control groups.Conclusion The prevalence of T2D is increasing in the Lebanese population compared to prior reports. These results should be considered to guide effective public health preventive strategies.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] The Gut Microbiome and Puberty in Girls at Risk for Type 2 Diabetes (T2D)
    Jobira, Beza
    Frank, Daniel N.
    Pyle, Laura
    Gross, Susan
    Ir, Diana
    Pendleton, Wesley
    Robertson, Charles E.
    Nadeau, Kristen J.
    Kelsey, Megan M.
    DIABETES, 2019, 68
  • [32] Mechanisms of the Antihyperglycemic Effect of Sitagliptin in Patients with Type 2 Diabetes (T2D)
    Muscelli, Elza
    Casolaro, Arturo
    Gastaldelli, Amalia
    Mari, Andrea
    Seghieri, Giuseppe
    Chen, Yu
    Alba, Maria
    Holst, Jens
    Ferrannini, Ele
    DIABETES, 2011, 60 : A267 - A267
  • [33] Association of MRS-derived bone marrow adiposity with serum lipids in type 2 diabetes (T2D)
    Wu, Po-hung
    Joseph, Gabby
    Pirmoazen, Amir
    Li, Yan
    Xu, Kaipin
    Li, Xiaojuan
    Schafer, Anne
    Schwartz, Ann
    Link, Thomas
    Kazakia, Galateia
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 316 - 316
  • [34] Replication and extension of type 2 diabetes (T2D) genome-wide association scan results in the Diabetes Prevention Program
    Moore, Allan F.
    Jablonski, Kathleen A.
    Mcateer, Jarred B.
    Saxena, Richa
    Pollin, Toni I.
    Franks, Paul W.
    Hanson, Robert L.
    Shuldiner, Alan R.
    Knowler, William C.
    Altshuler, David
    Florez, Jose C.
    DIABETES, 2008, 57 : A332 - A332
  • [35] Effectiveness of a screening program of type 2 diabetes (T2D) in Primary Care, and long-term incidence of T2D in Spain
    Gabriel, R.
    Vazquez-Fernandez, A.
    Marques, P.
    Novella, B.
    Moreno, S.
    Vega, S.
    Gonzalvez, L.
    Arranz, M.
    Melero, M. C.
    Montero Herrero, M. R.
    Acosta Vergara, T.
    Tuomilehto, J.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 197
  • [36] Dapagliflozin (DAPA) in Patients with Type 2 Diabetes (T2D) and Mixed Dyslipidemia
    Bays, Harold E.
    Sartipy, Peter
    Xu, John
    Langkilde, Anna Maria
    Sjostrom, C. David
    DIABETES, 2016, 65 : A306 - A306
  • [37] Renal Impairment and Antidiabetic Medication Use in Type 2 Diabetes (T2D)
    Koro, Carol E.
    Stender, Monika
    Sowell, Margaret
    Bourgeois, Nancy
    Spain, C. Victor
    DIABETES, 2014, 63 : A636 - A636
  • [38] Genomic Data and Disease Forecasting: Application to Type 2 Diabetes (T2D)
    Sirovich, Lawrence
    PLOS ONE, 2014, 9 (01):
  • [39] PowerHouse: A Lifestyle Intervention for Youth at Risk for Type 2 Diabetes (T2D)
    El Mikati, Hala K.
    Pike, Julie
    Haberlin-Pittz, Katie
    Yazel-Smith, Lisa
    Mckinney, Brett M.
    Hannon, Tamara S.
    DIABETES, 2019, 68
  • [40] Diabetes Distress, Depression, Perceived Stress, and Medication Adherence in Type 2 Diabetes (T2D)
    Mustafiz, Fayel
    Hoogendoorn, Claire J.
    Gonzalez, Jeffrey S.
    DIABETES, 2022, 71